Skip to main content

View full-text article in PMC

. 2015 Aug 7;36(11):4407–4420. doi: 10.1002/hbm.22928

Table 3.

Regional QSM and R2^* values for patients with early‐stage Parkinson's disease (all patients combined) and healthy controls

		Susceptibility (ppm)			R2^* Value (sec⁻¹)
		PD	HCs	P	PD	HCs	P
Head of caudate	Ipsilateral	0.038 ± 0.0095	0.039 ± 0.0065	1.000	28.2 ± 3.08	28.5 ± 2.76	1.000
Head of caudate	Contralateral	0.040 ± 0.0102	0.039 ± 0.0065	0.971	28.4 ± 3.61	28.5 ± 2.76	1.000
Putamen	Ipsilateral	0.039 ± 0.0097	0.046 ± 0.0111	0.013	33.0 ± 4.56	33.8 ± 4.42	1.000
Putamen	Contralateral	0.038 ± 0.0091	0.046 ± 0.0111	0.006	33.1 ± 5.05	33.8 ± 4.42	1.000
Globus pallidus	Ipsilateral	0.110 ± 0.0259	0.102 ± 0.0150	0.342	44.2 ± 4.92	42.6 ± 3.99	0.287
Globus pallidus	Contralateral	0.110 ± 0.0307	0.102 ± 0.0150	0.388	44.2 ± 5.08	42.6 ± 3.99	0.294
Red necleus	Ipsilateral	0.091 ± 0.0183	0.081 ± 0.0145	0.018	34.7 ± 4.19	33.8 ± 4.47	1.000
Red necleus	Contralateral	0.093 ± 0.0189	0.081 ± 0.0145	0.002	35.3 ± 4.80	33.8 ± 4.47	0.455
Substantia nigra	Ipsilateral	0.100 ± 0.0165	0.0837 ± 0.0156	<0.001	38.1 ± 5.26	34.9 ± 4.41	0.026
Substantia nigra	Contralateral	0.100 ± 0.0183	0.0837 ± 0.0156	<0.001	38.9 ± 5.91	34.9 ± 4.41	0.004

Data are presented as mean ±(SD).

Bold, P<0.005, significantly different from controls after the Bonferroni correction.